æŠèŠ
ããæ£è ã«è¿ãäœçœ®ã§è¿ éã«æ€æ»ã宿œãããã€ã³ããªãã±ã¢ïŒPoCïŒPoint-of-CareïŒã®æ®åãé²ãã§ããŸããã€ãŸããèªååã«å¯Ÿå¿ããæ€æ»æ©é¢ä»¥å€ã§ãäœå€èšºæïŒIVDïŒIn Vitro DiagnosticïŒãåºãè¡ãããããã«ãªã£ãŠããŸãããã ãPoCã®æŠå¿µã«åºã¥ãæ€æ»ïŒä»¥äžãPoCæ€æ»ïŒã«ã¯çžå¿ã®ãªã¹ã¯ã䌎ããŸããæ¬çš¿ã§ã¯ããŸãPoCæ€æ»ã«æœãã»ãã¥ãªãã£äžã®èª²é¡ã«ã€ããŠèª¬æããŸãããŸããæ£è ã®æ€äœã®å䜿çšãäžæ£äœ¿çšã®åœ±é¿ã«ã€ããŠè§£èª¬ãå ããŸãããã®äžã§ãã»ãã¥ã¢ãªé»åèªèšŒãæ¡çšããããšã«ãããPoCæ€æ»ãæ±ãããªã¹ã¯ãã©ã®ããã«è»œæžãããã®ããæããã«ããŸãã
ã¯ããã«
人äœããæ¡åããæ€äœã®æ€æ»ãè¡ãã蚺æãäžãããã«ã¯ãäžé£ã®å°éçãªåŠçãå¿ èŠã«ãªããŸãããããäœæ¥ã¯ãé·å¹Žã«ãããèšåºæ€æ»æ©é¢ã«äžä»»ãããŠããŸãããããããçŸåšã§ã¯ãã®ç¶æ³ã«å€åãçããŠããŸããã€ãŸããPoCæ€æ»ãæ®åããæ€äœã®åŠçã鿥å»é¢ã蚺çæãç é¢ãæŽã«ã¯èªå® ã§ãè¡ãããããã«ãªã£ãŠããã®ã§ããPoCæ€æ»ã§ã¯ãé¢ããå Žæã«ããæ€æ»æ©é¢ã«æ€äœãéä»ããå¿ èŠã¯ãããŸããããã®ãããããè¿ éã«èšºæçµæãåŸãããšãã§ããŸãããã®ããšã¯æãããªã¡ãªããã§ãããŸããã¯ãŒã¯ãããŒãå€§å¹ ã«æ¹åããæ£è ã«å¯ŸããŠæŽãªãå©äŸ¿æ§ãæäŸã§ããå¯èœæ§ããããŸããæ°åã³ãããŠã€ã«ã¹ææçïŒCOVID-19ïŒã®ãã³ãããã¯ãçããããšã«ãããå ç¢æ§ã®é«ãPoCæ€æ»ã®å¿ èŠæ§ã¯ããé¡èã«ãªããŸãããå®éããã³ãããã¯ãå§ãŸã£ãŠããæåã®æ°ãµæéã¯ãæ€æ»ã®é ãã瀟äŒã«æ·±å»ãªåœ±é¿ãåãŒããŸããããã®çµæããŠã€ã«ã¹ã®æ¡æ£ã«ãã€ãªãããŸããã
ä»åŸãPoCæ€æ»ã¯ããäžå±€æ®åãããšèããããŸããå®éãæ€æ»ïŒèšºæè£ 眮ã®ã¡ãŒã«ãŒã¯ãåŒåžåšçšã®ããã«ãæ§ææçïŒSTIïŒSexually Transmitted InfectionsïŒã®æ€æ»æ©èœãè¡æµææçã®æ€æ»æ©èœãªã©ãè€æ°ã®æ€æ»ã察象ãšããããã«ã¢ãã»ã€ïŒæ€æ»ææ³ïŒã®ããŒããã©ãªãªãæ¡åŒµããŠããŸãããã®ãããªè£ 眮ã®åžå Žã®æ¡å€§ã«äŒŽããæ€æ»æ©é¢ä»¥å€ã®å Žæã§åŠçãããæ€äœã®æ°ã¯çå®ã«å¢ããŠããŸãããã®çµæãæ€äœã¯å³æ Œã«å¶åŸ¡ãããã¯ãŒã¯ãããŒã«åŸã£ãŠå°éå®¶ã ããåãæ±ããã®ã§ã¯ãªããªããŸããã蚺çæã§å»åž«ãåŠçãè¡ãããšãããã°ãèªå® ã§æ£è èªèº«ãæ±ãã±ãŒã¹ããããŸãããã®çµæã1ã€ã®å€§ããªèª²é¡ãæµ®äžããŸããããã¯ãæ€äœã®å䜿çšãäžæ£äœ¿çšã®ãªã¹ã¯ãé«ãŸã£ãŠããŸããšãããã®ã§ãã
PoCæ€æ»ãæ±ãããªã¹ã¯
äžè¿°ããããã«ãPoCæ€æ»ã«ã¯æ€äœã®å䜿çšïŒäžæ£äœ¿çšãåœè£ ã®ãªã¹ã¯ã䌎ããŸããPoCæ€æ»ã®ã¡ãªãããæå€§éã«æŽ»ããã«ã¯ãã·ã¹ãã ããåºåãããæ€æ»çµæãæ£è ãšå»åž«ã®äž¡æ¹ã«ãšã£ãŠä¿¡é Œã§ãããã®ã«ãªãããã«ããªããã°ãªããŸãããäŸãã°ã枬å®ç²ŸåºŠã¯ãã®ããã®éåžžã«éèŠãªèŠçŽ ã§ããæ£ç¢ºãªçµæãåŸãããªããã°ã誀ã£ã蚺æãè¡ãããããããããããšã¯æããã§ããããäžæ¹ã§ãéåžžã«é«ç²ŸåºŠãªæ€æ»ãå®çŸããããšããŠãã誀ã£ãæ€äœãåŠçãããã°ã誀ã£ã蚺æãäžãããããšã«ãªããŸãããããã£ãŠãæ£è ã®æ€äœãæ£ããåãæ±ãããŠããããšã確èªããææ®µãäžå¯æ¬ ãšãªããŸããããã«ãããä¿¡é Œã§ããçµæãåŸãããããã«ãã誀ã£ã蚺æãè¡ããããªã¹ã¯ãåé¿ããªããã°ãªããŸããã
æ€äœã«ã€ããŠã¯ãããã€ãã®ãªã¹ã¯èŠå ãååšããŸããç¹ã«æ³šæãã¹ããªã®ã¯ãå䜿çšã®å¯èœæ§ã§ããããã¯ã誀ã£ãŠ1ã€ã®ç¶¿æ£ãã«ãŒããªããžãæ€æ»è£ 眮ã§è€æ°ååŠçããŠããŸã£ãå Žåã«çããå¯èœæ§ããããŸããäŸãšããŠãäœäººãã®å®¶æãå¿ããåºå ¥ããããããã³ã§ãåäŸãã¡ãæåŠæ ¡ã«è¡ãåã«èªå® ã§æ€æ»ã宿œããããšããŠããç¶æ³ãæãæµ®ãã¹ãŠã¿ãŠãã ããã1人ã®åäŸã®ç¶¿æ£ããå¥ã®åäŸã®ãã®ãšééã£ãŠå䜿çšããŠããŸããšãã£ãããšã容æã«èµ·ããããã§ãããããšåããªã¹ã¯ã¯ã蚺çæããç°¡æãªèšåºæ€æ»ã ãã宿œã§ããæ€æ»æ©é¢ãæ±ããŠããŸããããããæ€æ»æ©é¢ã¯ãCLIAïŒClinical Laboratory Improvement AmendmentsïŒ Waiverã®èªèšŒãååŸããŠããã¯ãã§ããããããããããæ€æ»æ©é¢ã«ã¯ãã¬ãŒãã³ã°ãåããæ€æ»æåž«ãåžžé§ããŠãããšã¯éããŸããããã®ãããªæ€æ»æ©é¢ããŸããŸãå¢å ããŠããã®ã§ãã
ãã1ã€ã®äž»èŠãªãªã¹ã¯ã¯ãæ€äœãæå³çã«äžæ£äœ¿çšãããŠããŸãå¯èœæ§ããããšãããã®ã§ããäŸãã°ãéæ³è¬ç©ã«é¢ããæ€æ»ãªã©ã§ã¯ã被éšè ãçµæãåœè£ ããããšèããã±ãŒã¹ãããåŸãŸããã€ãŸããæ€æ»ã®ããã®åŠçãè¡ãåã«æ€äœã®ã«ãŒããªããžãå¥ã®ãã®ã«å·®ãæ¿ãããšããããšãè¡ãããå¯èœæ§ããããŸããæ£ç¢ºãªçµæã®ååŸãé»ãŸãããªã¹ã¯èŠå ã¯ãã1ã€ãããŸããããã¯ãã«ãŒããªããžãªã©ã®åœé åãåžå Žã«åºåããšãããã®ã§ããåŸæ¥ã®æ€æ»æ©é¢ã¯ãæ£èŠã®è²©å£²ã«ãŒãã§ã«ãŒããªããžãªã©ãè³Œå ¥ããŠããŸããããã«å¯Ÿããèªå® ã§è¡ãããPoCæ€æ»ã§ã¯ããªã³ã©ã€ã³ã®å€§æå°å£²æ¥è ããæ£è ãçŽæ¥æ€æ»ããããè³Œå ¥ããã±ãŒã¹ãå°ãªããããŸãããããã«åœé åã®äŸçµŠæ¥è ãå ¥ã蟌ãäœå°ããããŸããçµæãšããŠã粟床ã®äœãçµæããåŸãããªãå質ã®äœãã«ãŒããªããžãªã©ã販売ãããå¯èœæ§ããããŸãã
æ€æ»æ©é¢ãå©çšããåŸæ¥ã®ææ³ã§ããäžæ£äœ¿çšãçããå¯èœæ§ããªãããã§ã¯ãããŸãããæ€æ»æ©é¢ã§äœ¿çšæžã¿ã®æ€æ»ãããã¯ãå»ç廿£ç©ãšããŠåŠçãããŸãããã®å»ç廿£ç©ã¯ããµãŒãããŒãã£ã«ãã£ãŠååãããŸããããã§ãæ€æ»ããããæ¹é ãããŠæ€æ»æ©é¢ã«å販売ããããšãããªã¹ã¯ãçããŸããæ¹é ãããæ€æ»ãããã¯æ°åã®ããã«èŠããŸãããå®ã¯è©Šè¬ãå«ãŸããŠããªãã£ãããåã«æ°Žãå å¡«ãããŠããã ãã ã£ããããŸããããããæ€æ»æ©é¢ã¯ãã®ãããªããšãç¥ãç±ããããŸããããã®ããã誀ã£ãæ€æ»çµæãåŸãããããšã«ãªããæ£è ã«å¯ŸããŠäžé©åãªåŠçœ®ãè¡ãããŠããŸããŸãã
æ€äœã®å䜿çšãäžæ£äœ¿çšã®åœ±é¿ã¯ãæ£è ãšè£ 眮ã¡ãŒã«ãŒã®äž¡æ¹ã«åã¶å¯èœæ§ããããŸãããŸããæ£è ã«ãšã£ãŠã¯èª€ã£ã蚺æãäžããããšãããªã¹ã¯ãçããŸããäŸãã°ãéœæ§ãšããå€å®ã誀ã£ãŠããå Žåãäžå¿ èŠã«æ¥åžžç掻ãäžæããäžå¿ èŠãªåŠçœ®ãåããããšã«ãªããããããŸãããéã«é°æ§ãšããå€å®ã誀ã£ãŠããå Žåã«ã¯ãé©åãªèšºæãé ããæ£ããåŠçœ®ãåããã®ãé ããªã£ãŠããŸã£ããåããããªãã£ãããããããããããŸããäžæ¹ãè£ çœ®ã®ã¡ãŒã«ãŒãšããŠã¯ãèªç€Ÿã®ãã©ã³ãã«å·ãã€ãå¯èœæ§ããããŸãããã®ã¡ãŒã«ãŒã®è£ 眮ã¯äžæ£ç¢ºã ãšããäžåœãªã¬ããã«ã貌ãããŠããŸããããããªããšããããšã§ããææªã®å Žåãååã®ãªã³ãŒã«ã«ã€ãªãããªã©ã倧ããªä»£åãæãããšã«ãªããããŸãããåœé ã«ãŒããªããžã®èå»¶ã¯ãè£ çœ®ã®ã¡ãŒã«ãŒã«ãšã£ãŠããžãã¹äžã®æ·±å»ãªãªã¹ã¯ã«ã€ãªããå¯èœæ§ããããŸããæ€æ»çšã®ã«ãŒããªããžã«ãã£ãŠç²åŸããŠããäœ¿ãæšãŠååãšããå©ççã®é«ãåçæºããªããªã£ãŠããŸããããããªãã®ã§ãã
ãªãåŸæ¥ã®ãœãªã¥ãŒã·ã§ã³ã§ã¯äžååãªã®ãïŒ
åŸæ¥ãæ€äœã®çæ£æ§ã確èªããããã«ã¯2ã€ã®æ¹æ³ã䜿ãããŠããŸããã1ã€ã¯ã1次å ïŒ2次å ã®ããŒã³ãŒããšãã£ãã©ãã«ãä»å ãããšãããã®ã§ãããã®æ¹æ³ã¯ãæ€æ»æ©é¢ã«ãããŠæ€äœã远跡ããããã«åºã䜿çšãããŠããŸãããããæ å ±ãã·ãªã¢ã«ã»ãã³ããŒãããã€ã¹åºæã®èå¥åïŒUDIïŒUnique Device IdentificationïŒã䜿çšããããšã§ãã«ãŒããªããžã®çæ£æ§ã確èªããããšãå¯èœã«ãªããŸãããŸããæ€äœãåŠçããåã«ããŒã³ãŒãã調ã¹ãã°ãå䜿çšãèµ·ããŠããªãããšã確èªã§ããŸããå®éãããŒã³ãŒãã¯æ€äœã®çæ£æ§ã確èªããããã®å ç¢ãªææ®µã ãšèšããŸããäœããããã€ãã®å¶çŽããããŸãããŸããããŒã³ãŒããèªã¿åãã«ã¯å°çšã®ã¹ãã£ããå¿ èŠã§ãããã®ãããæ€æ»è£ 眮ã®èšèšã«ã¯ããµã€ãºãçŠç¹è·é¢ã®èŠä»¶ã«åºã¥ãå¶çŽã課ããããŸãããŸããããŒã³ãŒãã䜿çšããå Žåãå䜿çšãé²ãããã«ååãªæ°ã®ã·ãªã¢ã«ã»ãã³ããŒãçšæããããšã«ãªããŸãããã®æ å ±ãæ ŒçŽããã«ã¯ããªãã®éã®ã¡ã¢ãªãå¿ èŠã§ãããã®ããšã¯ãæ€æ»æ©é¢ã«é åããã倧åã®è£ 眮ã§ã¯åé¡ã«ãªããªããããããŸãããããããPoCæ€æ»çšã®ã³ã³ãã¯ããªè£ 眮ã®å Žåã¯ãã³ã¹ããšãµã€ãºã®é¢ã§èª²é¡ã«ãªããŸããæŽã«æ±ºå®çãªåé¡ç¹ããããŸããããŒã³ãŒãã¯ç®èŠãå¯èœãªãã®ã§ãããã®ãããæ¬è³ªçã«ã¯å®å šæ§ãé«ããšã¯èšããŸãããå®éããããåå ã§æš¡å£ãåœé ãè¡ãããã±ãŒã¹ããããŸãã
æ€äœã®çæ£æ§ã確èªããããã®ãã1ã€ã®æ¹æ³ã¯ãã«ãŒããªããžã®åæ¿å ¥ãé²ãããã®æ©æ¢°çãªæ§é ãæ¡çšãããšãããã®ã§ããã«ãŒããªããžã«ãè£ çœ®ã«äžåºŠæ¿å ¥ãããšåœ¢ç¶ãäœçœ®ãå€åããããããèšãããªã©ãç°¡çŽ ãªæ©æ¢°çãªæ§é ãé©çšãããšããããšã§ãããã®ãããªæ§é ã«å¯Ÿå¿ããã·ã¹ãã ã¯äœã³ã¹ãã§å®çŸã§ããŸãããã®ãããå䜿çšã鲿¢ããããã®ç°¡äŸ¿ãªææ³ã ãšèšããŸããäœãããã¹ãŠã®ã«ãŒããªããžã«åäžã®æ§é ãèšããããšã«ãªãã®ã§ãåã ã®æ€äœãåºå¥ããããã®ææ®µã«ã¯ãªããŸããããŸãããããã®é¡ã¯ç®èŠãå¯èœãªã®ã§ããããã³ããŒããã®ã¯é£ãããããŸãããã€ãŸãããã®èšèšã¯åœé ã«å¯ŸããŠã¯è匱ã ãšããããšã§ããå ããŠãæ©æ¢°çãªæ§é ã¯ã鿣èŠã®æ¥è ã«ãã£ãŠäœ¿çšæžã¿ããããæ¹é ãããéã«ãªã»ããã§ããå¯èœæ§ããããŸããæŽã«ãPoCæ€æ»çšã®è£ 眮ã®å°ååãé²ãã«ã€ããã«ãŒããªããžã«æ©æ¢°çãªæ§é ãèšããããšãèšèšäžã®è² æ ã«ãªããŸãã
é»åèªèšŒã®é©çšãæ€æ»ã®ä¿¡é Œæ§ã®åäž
PoCæ€æ»ã«å¯ŸããŠçæ³çãªãœãªã¥ãŒã·ã§ã³ãèŠãã ãã«ã¯ã©ãããã°ããã®ã§ããããããã®ããã«ã¯ãåŸæ¥ã®æ¹æ³ãšã¯ç°ãªãæ¹åã«ç®ãåããå¿ èŠããããŸãããããããšãã«ãŒããªããžã«çµã¿èŸŒãããšãå¯èœãªICã«ãã£ãŠé»åèªèšŒã宿œãããšããè§£ãèŠããŠããŸããå®éãé»åèªèšŒçšã®ICã¯ãã«ãŒããªããžã®å䜿çšïŒäžæ£äœ¿çšãé²ãå ç¢æ§ã®é«ãææ®µã«ãªãåŸãŸãããŸããé»åèªèšŒçšã®ICã«ã¯ã»ãã¥ã¢ãªãã¯ãªã¡ã³ãã»ã«ãŠã³ã¿ãå®è£ ãããŸããããã¯ãå䜿çšãé²ãããã«äœ¿ããããã®ã§ããã€ãŸããåå䜿çšã®ã«ãŒããªããžã1床ããåŠçãããªãããšãä¿èšŒãã圹å²ãæãããŸãããŸãããã®çš®ã®ICã«ã¯äžæçãªèå¥çªå·ïŒãŠããŒã¯ãªIDïŒãå²ãæ¯ãããšãã§ããŸãããã®ãããåã ã®æ€äœãåºå¥ããããšãå¯èœã«ãªããŸããäžæ£äœ¿çšã®å¯èœæ§ã«ã€ããŠã¯ãæå·ãããŒã¹ãšãããã£ã¬ã³ãžã¬ã¹ãã³ã¹ã»ã¢ã«ãŽãªãºã ã«ãã£ãŠå¯ŸåŠããŸãããã®ææ³ãå©çšããããšã§ããµãŒãããŒãã£ã®ã¡ãŒã«ãŒã«ããã«ãŒããªããžã®åœé ãé²ãããšãå¯èœã«ãªããŸãããã以å€ã«ããèªèšŒçšã®ICã«ã¯ãã¿ã€ã ã¹ã¿ã³ãã«ãã£ãŠäœ¿çšå±¥æŽãã»ãã¥ã¢ã«èšé²ããæ©èœãªã©ãå®è£ ãããŸãããã®æ©èœã¯ãæ€æ»ãé »ç¹ã«å®æœããå¿ èŠãããå Žåããæ¯æ¥æ±ºãŸã£ãæéã«æ€æ»ãè¡ããªããã°ãªããªãå Žåã«åœ¹ç«ã€å¯èœæ§ããããŸãã
ããŒã³ãŒããæ©æ¢°çãªæ§é ãšã¯ç°ãªããé»åèªèšŒã®ãœãªã¥ãŒã·ã§ã³ã¯ã«ãŒããªããžã®å éšã«çµã¿èŸŒãŸããŸãããã®ããããŠãŒã¶ãŒãåœé æ¥è ãç®ã«ããããšã¯ãããŸããããããã£ãŠãããã»ãã¥ã¢ãªãœãªã¥ãŒã·ã§ã³ã ãšèšããŸããèªèšŒçšã«å°ããªICã䜿çšããããšãããPoCæ€æ»çšã®ã·ã¹ãã ã®ãµã€ãºã«é¢ããèšèšäžã®å¶çŽã軜æžãããŸãã
é»åèªèšŒçšã®ICãæ¡çšããããšã«ãããæ€äœã®ã«ãŒããªããžã®å䜿çšãäžæ£äœ¿çšã®ãªã¹ã¯ãå€§å¹ ã«è»œæžãããŸããèšãæããã°ãæ£è ãšè£ 眮ã®ã¡ãŒã«ãŒã«å¯Ÿããæ€æ»çµæã¯çæ£ãã€ä¿¡é Œã§ãããã®ã ãšããããšãäžå®ã®ã¬ãã«ã§ä¿èšŒãããŸãã
ã¢ããã°ã»ããã€ã»ãºã®é»åèªèšŒãœãªã¥ãŒã·ã§ã³
ã¢ããã°ã»ããã€ã»ãºã¯ãé»åèªèšŒçšã®IC補å矀ãæäŸããŠããŸãããããã®äžã«ã¯ãæå·åæè¡ã«é¢ããåºç¯ãªç¥èããªããŠãPoCæ€æ»çšã®ã«ãŒããªããžã«ç°¡åã«çµã¿èŸŒãããã®ãå«ãŸããŠããŸããã€ãŸããå®å šãªã¿ãŒã³ããŒã»ãœãªã¥ãŒã·ã§ã³ãå®çŸãããŠãããšããããšã§ãã
ã»ãã¥ã¢èªèšŒçšã®åICã«ã¯ã64ãããã®äžæçãªã·ãªã¢ã«ã»ãã³ããŒãå²ãæ¯ãããŠããŸããããã«ãããã«ãŒããªããžãŸãã¯è£ 眮ã®ã»ãã¥ã¢ãªèå¥ãšãã¬ãŒãµããªãã£ãå®çŸããããšãã§ããŸããã»ãã¥ã¢ãªå èµã¡ã¢ãªã¯ã補é ã«é¢ããæ å ±ããã£ãªãã¬ãŒã·ã§ã³çšã®ãã©ã¡ãŒã¿ãªã©ã®æ©å¯ããŒã¿ãä¿è·ããæ¹ãããé²ã圹å²ãæãããŸãããŸããèªèšŒã®åŠçã«ã¯æ¥çæšæºã®æè¡ã䜿ãããŸããå ·äœçã«ã¯ãæå·ã¢ã«ãŽãªãºã ãšããŠã察称éµã®SHAïŒSecure Hash AlgorithmïŒ-2/SHA-3ãŸãã¯é察称éµã®ECDSAïŒElliptic Curve Digital Signature AlgorithmïŒã䜿ãããŸããããã«ãããã«ãŒããªããžãæ£èŠåã§ããããšã確èªãããµãŒãããŒãã£ã«ããåœé åã®äœ¿çšãé²ãããšãå¯èœã«ãªããŸããå ããŠããã¯ãªã¡ã³ãå°çšã®ã»ãã¥ã¢ãªå èµã«ãŠã³ã¿ã«ããã«ãŒããªããžã®ç®¡çãç°¡çŽ åãããŸããäœ¿ãæšãŠã«ãŒããªããžã®å䜿çšã鲿¢ãããŸããPoCæ€æ»ã®ã¢ããªã±ãŒã·ã§ã³ã«æé©ãªè£œåã«ã¯ããã€ãã®ããªãšãŒã·ã§ã³ããããŸããäŸãã°ãéä¿¡ã€ã³ã¿ãŒãã§ãŒã¹ãšããŠã·ã³ãã«ãª1-Wire®ã䜿çšãããDS28E16ãããNFCã«å¯Ÿå¿ããéæ¥è§Šã€ã³ã¿ãŒãã§ãŒã¹ãåãããMAX66250ããªã©ããããŸããã¢ããã°ã»ããã€ã»ãºã®é»åèªèšŒçšICã¯ãå°çšã®ããªã³ãåºæ¿ãçšæããããšãªãèšèšã«çµã¿èŸŒãããšãå¯èœã§ããã€ãŸããPoCæ€æ»çšã®ã³ã³ãã¯ããªã·ã¹ãã ã®èšèšãç°¡çŽ åãããœãªã¥ãŒã·ã§ã³ãšããŠå®çŸãããŠããŸãã
ãŸãšã
PoCæ€æ»ã®å°å ¥ãé²ãã ããšã«ãããæ€äœã®ã»ãã¥ãªãã£ãšãã¬ãŒãµããªãã£ã確ä¿ããããšãéèŠã«ãªã£ãŠããŸããäžæ¹ã§ãæ€æ»è£ 眮ã«ã€ããŠã¯å°ååã«å¯ŸããããŒãºãé«ãŸã£ãŠããŸããPoCæ€æ»ã«äŒŽããªã¹ã¯ãé¡åšåããçµæãæ€äœã远跡ããããã®åŸæ¥ã®ææ®µïŒæ€æ»æ©é¢ã§åºãæ¡çšãããŠãã远跡çšã®ããŒã³ãŒããªã©ïŒãæ±ãã課é¡ãæããã«ãªããŸãããã¢ããã°ã»ããã€ã»ãºã¯DS28E16ãªã©ã®é»åèªèšŒçšã®ICãæäŸããŠããŸããããããæ¡çšããã°ãPoCæ€æ»çšã®ã·ã¹ãã ã®èšèšãç°¡çŽ åããããšãã§ããŸãããŸããè£ çœ®ã¡ãŒã«ãŒã«ãšã£ãŠã®ã»ãã¥ãªãã£äžã®ãªã¹ã¯ãç·©åããããšãå¯èœã§ããæŽã«ã蚺æã®èª€ããé ããè£ çœ®ã®ãªã³ãŒã«ãªã©ã®å¯èœæ§ãäœãæããããŸãã